A triple-mode strategy on JQ1-loaded nanoplatform for superior antitumor therapy in pancreatic cancer
{{output}}
Pancreatic cancer's dire prognosis urgently calls for innovative therapeutic strategies. JQ1, a bromodomain 4 inhibitor, exhibits potent anti-tumor activity in preclinical models but faces limitations due to rapid resistance development. Here, we developed a ... ...
